Literature DB >> 3056036

Action of the cholecystokinin antagonist L364,718 on gastric emptying in the rat.

T Green1, R Dimaline, S Peikin, G J Dockray.   

Abstract

Cholecystokinin (CCK) is a potent inhibitor of gastric emptying. We have examined the effects of a novel potent peripheral CCK receptor antagonist (L364,718) on the action of endogenous and exogenous CCK octapeptide (CCK-8) on gastric emptying in the rat. In conscious gastric fistula rats, the recovery of liquid test meals of 3.0 ml (containing phenol red as a dilution marker) was determined over periods up to 8 min. Compared with saline, gastric emptying of solutions of peptone (4.5%), 50 mM HCl, and hyperosmolal saline was significantly delayed. The emptying of saline was also delayed by intravenous infusion of CCK-8 (400 pmol.kg-1.h-1). The CCK antagonist L364,718 reversed the effect of peptone in a dose-dependent manner and inhibited the response to exogenous CCK, but the emptying of physiological saline, 50 mM HCl, or hyperosmolal saline remained unchanged. A protease inhibitor (FOY-305) that is thought to release endogenous CCK by inhibiting negative feedback control by luminal proteases also delayed emptying, and this response was inhibited by L364,718. We conclude that CCK has a physiological role in the mediation of the effect of proteins on gastric emptying in the rat.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3056036     DOI: 10.1152/ajpgi.1988.255.5.G685

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  14 in total

1.  Relation between cholecystokinin and antral innervation in the control of gastric emptying in the rat.

Authors:  A Higham; C Vaillant; B Yegen; D G Thompson; G J Dockray
Journal:  Gut       Date:  1997-07       Impact factor: 23.059

Review 2.  Diet: friend or foe of enteroendocrine cells--how it interacts with enteroendocrine cells.

Authors:  Sofia Moran-Ramos; Armando R Tovar; Nimbe Torres
Journal:  Adv Nutr       Date:  2012-01-05       Impact factor: 8.701

3.  Decreased gastric mechanodetection, but preserved gastric emptying, in CCK-1 receptor-deficient OLETF rats.

Authors:  Bart C De Jonghe; Andras Hajnal; Mihai Covasa
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2006-05-25       Impact factor: 4.052

4.  Gastric emptying in OLETF rats not expressing CCK-A receptor gene.

Authors:  E Shoji; T Okumura; S Onodera; N Takahashi; K Harada; Y Kohgo
Journal:  Dig Dis Sci       Date:  1997-05       Impact factor: 3.199

5.  Postprandial normal saline intake delays gastric emptying of solids in conscious dogs: partial involvement of CCK in its mechanism.

Authors:  T Tanaka; A Mizumoto; S Muramatsu; E Mochiki; N Haga; H Suzuki; Z Itoh
Journal:  Dig Dis Sci       Date:  1999-08       Impact factor: 3.199

6.  Cefaclor, a cephalosporin antibiotic, delays gastric emptying rate by a CCK-A receptor-mediated mechanism in the rat.

Authors:  A Bozkurt; M Deniz; B C Yegen
Journal:  Br J Pharmacol       Date:  2000-10       Impact factor: 8.739

7.  Superior mesenteric artery blood flow and gastric emptying in humans and the differential effects of high fat and high carbohydrate meals.

Authors:  M B Sidery; I A Macdonald; P E Blackshaw
Journal:  Gut       Date:  1994-02       Impact factor: 23.059

8.  Physiological role of cholecystokinin on postprandial insulin secretion and gastric meal emptying in man. Studies with the cholecystokinin receptor antagonist loxiglumide.

Authors:  M Fried; W Schwizer; C Beglinger; U Keller; J B Jansen; C B Lamers
Journal:  Diabetologia       Date:  1991-10       Impact factor: 10.122

9.  [The Longmire gastrectomy in the animal model: postoperative changes in fat resorption and the hormones cholecystokinin and secretin].

Authors:  P Klein; B Reingruber
Journal:  Langenbecks Arch Chir       Date:  1994

10.  Reversal of the anorectic effect of (+)-fenfluramine in the rat by the selective cholecystokinin receptor antagonist MK-329.

Authors:  S J Cooper; C T Dourish; D J Barber
Journal:  Br J Pharmacol       Date:  1990-01       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.